Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 618-624

  Snell, Virginia ^a   Clodi, Katharina ^a   Zhao, Shourong ^a   Goodwin, Raymond ^d   Thomas, Elaine K ^d   Morris, Stephan W ^c   Kadin, Marshall E ^b   Cabanillas, Fernando ^a   Andreeff, Michael ^a   Younes, Anas ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d AMGEN INC   (United States)

Author keywords

Apoptosis; Fas ligand; Leukaemia; Lymphoma; TRAIL

Indexed keywords

ALITRETINOIN; FAS ANTIGEN; GLYCOPROTEIN P; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3; PERFORIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE TIME EFFECT RELATION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 9844225051     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4393250.x     Document Type: Article

References (24)

1. Bacigalupo, A., Soracco, M., Vassallo, F., Abate, M., Vanlint, M.T., Gualandi, F., Lamparelli, T., Occhini, D., Mordini, N., Bregante, S., Figari, O., Benvenuto, F., Sessarego, M., Fugazza, G., Carlier, P. & Valbonesi, M. (1997) Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation. Bone Marrow Transplantation, 19, 927-932.
2. Baker, S.J. & Reddy, E.P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene, 12, 1-9.
3. Braun, M.Y., Lowin, B., French, L., Acha-Orbea, H. & Tschopp, J. (1996) Cytotoxic T cells deficient in both functional fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. Journal of Experimental Medicine, 183, 657-661.
4. Chapman, R.S., Chresta, C.M., Herberg, A.A., Beere, H.M., Heer, S., Whetton, A.D., Hickman, J.A. & Dive, C. (1995) Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells. Cytometry, 20, 245-256.
5. Darzynkiewicz, Z. (1990) Differential staining of DNA and RNA in intact cells and isolated cell nuclei with acridine orange. Methods in Cell Biology, 33, 285-298.
6. Deeg, H.J. (1994) Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients. Bone Marrow Transplantation, 14, S56-S60.
7. Delia, D., Aillo, A., Formelli, F., Fontanella, E., Costa, A., Miyashita, T., Reed, J.C. & Pierotti, M.A. (1995) Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl2. Blood, 85, 359-367.
8. Ferrara, J.L. (1992) Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation. Bone Marrow Transplantation, 1, 10-12.
9. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J. & Puck, J.M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative symdrome. Cell, 81, 935-946.
10. Graf, D., Muller, S., Korthauer, U., van Kooten, C., Weise, C. & Kroczek, R.A. (1995) A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. European Journal of Immunology, 25, 1749-1754.
11. Gruss, H.J. & Dower, S.K. (1995) Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404.
12. Herve, P., Tiberghien, P., Racadot, E., Plouvier, E. & Cahn, J.Y. (1993) Prevention and treatment of acute GvHD: new modalities. Bone Marrow Transplantation, 1, 103-106.
13. Jaattela, M., Benedict, M., Tewari, M., Shayman, J.A. & Dixit, V.M. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene, 10, 2297-2305.
14. Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. (1994) Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature, 370, 650-652.
15. Nagata, S. & Golstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
16. Nagy, L., Thomazy, V.A., Shipley, G.L., Fesus, L., Lamph, W., Heyman, R.A., Chandraranta, R.A.S. & Davies, P.J.A. (1995) Activation of retinoic acid X receptors induced apoptosis in HL-60 cell lines. Molecular and Cellular Biology, 15, 3540-3551.
17. Pan, G.H., Orourke, K., Chinnaiyan, A.M., Gentz, R., Ebner, R., Ni, J. & Dixit, V.M. (1997) The receptor for the cytotoxic ligand TRAIL. Science, 276, 111-113.
18. Shalinsky, R.D., Bischoff, E.D., Gregory, M.L., Lamph, W.W., Heyman, R.A., Hayes, J.S., Thomazy, V. & Davis, J.A. (1996) Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamons cell carcinoma xenografts in nude mice. Clinical Cancer Research, 2, 511-520.
19. Soiffer, R.J. (1997) Donor lymphocyte infusions: the door is open. Journal of Clinical Oncology, 15, 416-417.
20. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H. & Nagata, S. (1996) Fas ligand in human serum. Nature Medicine, 2, 317-322.
21. Vermes, L. Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 39-51.
22. Wiley, S.R., Schooley, K., Smolak, P.J., Din, W.S., Huang, C.-P., Nicholl, J.K., Sutherland, G.R., Smith, T.D., Rauch, C., Smith, C.A. & Goodwin, R.G. (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-682.
23. Younes, A., Consoli, U., Zhao, S., Snell, V., Thomas, E., Gruss, H.J., Cabanillas, F. & Andreeff, M. (1996) CD30 ligand is expressed on resting normal and malignant human B lymphocytes. British Journal of Haematology, 93, 569-571.
24. Younes, A., Zhao, S., Jendiroba, D., Kleine, H.D., Cabanillas, F. & Andreeff, M. (1995) Decreased expression of the deleted in colorectal carcinoma gene in non-Hodgkin's lymphoma. Blood, 85, 2813-2816.